Status:
COMPLETED
Effects of Exercise Intervention and Confounding Factors on Type II Diabetic Muscles
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Diabetes and Healthy Control
FTO Gene Expression
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
The aim of the first year of this three-year plan is to analyze and compare the muscle quality of lower limb muscle (microcirculation, muscle performance and mechanical characteristics) and maximal ae...
Detailed Description
Participants with diabetes will attend an 12-week aerobic exercise intervention or home exercise if the exercise test result of the maximum rate of oxygen consumption is fair or poor. Assessments will...
Eligibility Criteria
Inclusion
- Diabetes group: 1) Age between 30-70 years of old, 2) type 2 diabetes.
- Healthy control group: 1) Age between 30-70 years of old, 2) without diabetes
Exclusion
- history of moderate-severe somatic or autonomic neuropathy, cardiovascular disease, preproliferative or proliferative retinopathy, and chronic renal failure
- unable to perform the programs or assessments
- other systematic diseases
Key Trial Info
Start Date :
August 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03869411
Start Date
August 15 2019
End Date
July 31 2020
Last Update
December 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100